User contributions
- 17:21, 22 November 2024 diff hist +6,392 N Coughlincormier5224 Created page with "citentan, riociguat, and selexipag sufficiently improved clinical parameters and was well tolerated in patients with PAH. This combination could be a particularly promising st..." current